by admin | Aug 1, 2022 | 2022
Breast Cancer is increasing at an alarming rate in Pakistan. 1in 9 women is prone to having breast cancer sometime in her life. This is a worrisome situation that calls for active efforts for screening this disease and nipping the evil in its bud. Mammography and...
by admin | Aug 1, 2022 | 2022
Cancer is a frightening and life changing diagnosis. Besides having a great impact on patient’s physical health, its effects on patient’s mental and emotional health are just as alarming. When it comes to breast cancer, there are so many other factors at play that...
by admin | Aug 1, 2022 | 2022
Breast cancer is the most common cancer among women in both under-developed, less-developed and developed countries. Rates of breast cancer are increasing around the globe, with a specific increase in postmenopausal and estrogen receptor-positive cases. The American...
by admin | Aug 1, 2022 | 2022
Breast Cancer is the most common non skin cancer in women. Every 1 in 9 women in Pakistan has a risk for developing breast cancer in her lifetime. Early detection of this disease is the only sure shot way of surviving breast cancer. Screening tests for any disease are...
by admin | Aug 1, 2022 | 2022
Breast cancer is the second leading cause of cancer deaths among women. The development of breast cancer is a multi-step process involving multiple cell types, and its prevention remains challenging in the world. 1 in every 9 women is at risk of breast cancer in...
by admin | Aug 1, 2022 | 2022
Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) is approved by the U.S. Food and Drug Administration to treat currently incurable HER-2-positive breast cancer and metastatic HER2-positive breast cancer that has been treated with two or more anti-HER2...
